keyboard_arrow_up

POC Diagnostic Market (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers) is expected to grow $27.5 Billion by 2018

The global point-of-care diagnostics market is expected to reach $27.5 billion by 2018, at a CAGR of 9.3% from 2013 to 2018. A number of factors such as the rising prevalence of lifestyle and infectious diseases, increasing usage of home-based POC devices, and decreasing number of technicians in central labs are driving the growth of the global market. Furthermore, growing government support and increasing private investments and venture funding to support new product development are other factors that are propelling the growth of the market. In addition, rising adoption of POC devices, expansion of therapeutic horizon, and technological advancements is further fueling the growth of this market.

Get PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=106829185

However, a few pivotal factors such as lack of alignment with definitive central lab methods, and reluctance to change existing treatment practices are hindering the growth of this market. Moreover, disadvantages of POC testing over central lab methods and recalls of leading glucose monitoring devices are the foremost challenges faced by industry players.

Inquiry Before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=106829185

New product launches is the key strategy followed by leading market players to ensure their growth in the POC diagnostics market. Moreover, partnerships, agreements, collaboration, and joint ventures; mergers and acquisitions; and expansions are some other growth strategies adopted by industry players in the global market.

The point-of-care diagnostics market is a diversified and competitive market with a large number of players. The market is dominated by various players, depending on their core competencies. The key players in this market are Roche Diagnostics Ltd. (Switzerland), Abbott Laboratories (U.S.), Alere Inc. (U.S.), Siemens AG (Germany), and Beckman Coulter, Inc. (U.S.).

Browse related reports:

Diagnostic Imaging Market by X-ray Systems (Digital, Analog, Portable), Computed Tomography, Ultrasound Imaging Systems (2D, 3D, 4D, Doppler), MRI Machines (Closed & Open), and Nuclear Imaging Systems (SPECT, PET, PET/CT) - Global Forecasts to 2018
 http://www.marketsandmarkets.com/Market-Reports/diagnostic-imaging-market-411.html

Global Nuclear Imaging Systems / Equipment Market (2011 - 2016) - PET (Positron Emission Tomography) & SPECT (Single Photon Emission Computed Tomography) Landscape
http://www.marketsandmarkets.com/Market-Reports/pet-market-98.html

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:

Mr. Rohan

North - Dominion Plaza

17304 Preston Road

Suite 800, Dallas, TX 75252

Tel: +1-888-600-6441

Email: sales@marketsandmarkets.com

Visit MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology

Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets